Cagatay Oktenli
- 4.6 Excelente • 508 avaliações
- 36 anos de experiência
- Turquia, Istambul, Anadolu Medical Center
Dr. Kayihan Engin is a Radiation Oncologist. He earned his medical degree from Uludağ University Medical College in 1983. He completed his residency in Radiation Oncology at the Center of Oncology & Nuclear Medicine in Istanbul in 1990. From 1990 to 1994, he pursued a post-doctoral fellowship in Thermoradiotherapy at Thomas Jefferson University in the USA.
Dr. Engin has held key academic and leadership roles. He served as Professor, Chairman, and Faculty Accreditation Coordinator at Uludağ University Medical College from 1991 to 2005. He was also Professor and Director at Anadolu Medical Center between 2004 and 2017. Since 2017, he has led the Oncological Sciences departments at Ceylan International and Medicana Bursa Hospitals. Dr. Engin is known for his work in improving cancer treatment and medical education standards in Turkey.
O Dr. Sertkaya formou-se na Konya Meram Science High School em 2001 e entrou na Faculdade de Medicina da Universidade Gazi no mesmo ano, graduando-se em 2008. Concluiu a sua especialização em urologia no Hospital de Treinamento e Pesquisa Haydarpaşa Numune em 2014, tornando-se especialista em urologia.
Desde que se tornou especialista, ele tem focado na subespecialidade de Andrologia, participando de diversas sessões de formação e conferências, além de realizar cirurgias com alguns dos principais professores de Andrologia do mundo. Em 2017, ele passou nos exames de competência escritos e orais conduzidos pela Associação Europeia de Urologia, obtendo o título de “FEBU”.
Em 2020, o Dr. Sertkaya alcançou o título de Professor Associado de Urologia. A sua jornada em Urologia e Andrologia, que começou em 2008, continua no Andro Expertise Male Health and Aesthetics Center, que fundou em 2022. Ele atende pacientes na sua própria clínica e realiza cirurgias em hospitais afiliados.
Ver portfólio
Prof. Dr. Sezer Sağlam is a medical oncologist at Gayrettepe Florence Nightingale Hospital. He specializes in gastrointestinal and breast cancers. He has contributed to cancer care through research, especially with his study on the best timing for surgery after neoadjuvant therapy in rectal cancer. This work has influenced global treatment protocols.
Dr. Sağlam has led clinical trials in targeted therapies and precision medicine. His research on liver-transplanted patients with hepatocellular carcinoma was nominated for the 2024 International Best Researcher Award. He is a member of ASCO, ESMO, and ENET. Dr. Sağlam provides personalized and evidence-based oncology care.
Personal Information
Sex: Male
Born : 1968
Professional Experience
Gayrettepe Florence Nigthingale Hospital
Medical Oncology Department
Besiktas/Istanbul/Turkey (ongoing)
Education:
He became Professor (22/April /2016)
Medical Oncology
Attending Phys.in Gastrointestinal Oncology (January 2005 ,2009)
Istanbul University Oncology Institue,
Department of Medical Oncology
Medical Oncology Fellowship (December 2001-December2004)
Istanbul University, Istanbul Medical Faculty
Hemodialysis Traning (May1996-January1997)
Istanbul University ,bCerrahpasa Medical Faculty
Internal Medicine Residency (November 1991-November 1996)
Istanbul University ,bCerrahpasa Medical Faculty
Ege University Medical Faculty (1985-1991)
Professional Experience
February 1999-November 2001
Metropolitan Florence Nigthingale Hospital
American Cancer Center, Gayrettepe/İstanbul
April1997- October 1998
Bayraktar Dialysis Center
Güngören/ Istanbul
Membership
Turkish Medical Oncology Association
ENET(European Neuroendocrine Tumour Society)
ESMO
ASCO
Education:
Roles in Projects:
Sub investigator (Assistant Researcher) in the SOUL Study: Cardiovascular Outcome Research of Semaglutide in Type 2 Diabetic Patients, approved by the Turkish Medicines and Medical Devices Agency on May 22, 2019.
Sub investigator (Assistant Researcher) in the international study “SCALE™ Insulin”: Efficacy and Safety of Liraglutide 3.0 mg in Overweight or Obese Patients with Type 2 Diabetes Treated with Basal Insulin (Study Code: NN8022-4272), conducted by Novo Nordisk A.Ş.
Subinvestigator (Assistant Researcher) in the international study NN5401-4266 StepByStep Intensification conducted by Novo Nordisk.
Assistant Researcher in the study "A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes (SUSTAIN 11)" (2019-2020).
Assistant Researcher in the PIONEER 1 study: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes.
Education
İnönü Üniversitesi Tıp Fakültesi (ingilizce) 1995- 2002
Work Experience
Başbakanlık S.H.Ç.E.K. Genel Müdürlüğü Kurum Hekimliği (2003)
Erciyes Üniversitesi Tıp Fakültesi Genel Cerrahi Uzmanlığı 2011
Yüzüncü Yıl Üniversitesi Temel ve İleri Düzey Endoskopik Girişimler Eğitimi 2011
İstanbul Hastanesi /Van 2011
Özel Malatya Hastanesi / Malatya2012
Bilgi Tıp Merkezi Keçiören /Ankara 2013
Özel Koru Sincan Hastanesi Sincan/Ankara 2013
Baş Tibb Mərkəzi /Baku Clinic Azerbaycan/Bakü 2013
Yüksek İhtisas Üniversitesi Özel Koru Ankara Hastanesi 2019
Özel Ankara Koru Hastanesi /Ankara 2019
Medical Interests
laparoscopic obesity
Laparoscopic abdominal and inguinal hernia repairs (with the latest techniques)
Postpartum laparascopic diastasis recti (the formation of a protrusion in the upper middle abdomen due to the separation of the muscles in the abdominal tissue) and abdominal hernias above the navel and and gobekustunde both diastasis recti repair and abdominal hernia repair from the skin with laparascopic scola method for the first time in Turkey laparascopic stomach hernia and antireflu surgery).
Laparoscopic gallbladder surgeries, including cleaning the bile duct with trans-cystic choledochal irrigation in patients with bile sludge and stones less than 5mm in the bile duct, performed in the same session
Laparoscopic gallbladder surgeries in pregnant women during the 2nd and 3rd trimesters, i.e., after 12 weeks of pregnancy
Laparoscopic Appendectomy in Pregnancy
Anal disorders, anal fissures, all types of internal and external hemorrhoid surgeries, anal fissure, and anal fistula surgeries
Thyroid surgeries and cancers, parathyroid surgeries and cancers
Breast diseases and breast cancer surgery
Oncological surgery; liver and gallbladder and bile duct surgeries, stomach cancer surgery, colon cancer surgery, and liver resections for metastatic liver tumors
Cumhuriyet University Faculty of Medicine, 2004
Istanbul Haydarpaşa Training and Research Hospital Internal Medicine Residency, 2010
Karadeniz Technical University Faculty of Medicine Medical Oncology Residency, 2015
MD Andeson Cancer Center, USA, 2008
Sunnybrook Odette Cancer Center Breast Cancer Clinic, Canada, 2017
Moffit Cancer Center , USA 2022
Istanbul Haydarpaşa Training and Research Hospital Internal Medicine, 2010
İdil State Hospital Internal Medicine Clinic, 2011
Karadeniz Technical Universityniversitesi Faculty of Medicine, Medical Oncology Clinic, 2015
Istanbul Göztepe Training and Research Hospital, Medical Oncology Clinic, 2018
Yeniyüzyıl University Gaziosmanpaşa Hospital, Medical Oncology Clinic, 2020
Ataşehir Medicana Hospital, Medical Oncology Clinic, 2022
Turkish Medical Association (TTB)
Turkish Society of Medical Oncology (TTOD)
European Society for Medical Oncology (ESMO)
American Society of Medical Oncology (ASCO)
Medical Intrests
Dr. Mehmet Yigit is an internal medicine specialist. He focuses on diabetes, metabolic syndrome, thyroid diseases, and hypertension. He also treats gastrointestinal problems such as dyspepsia, gastritis, and irritable bowel syndrome. In addition, he manages spondylitis and connective tissue diseases.
Dr. Yigit graduated from Çukurova University Faculty of Medicine in 2007. He completed his internal medicine training at Adnan Menderes University in 2013. He has worked as Assistant Chief Physician at Liv Hospital Ulus. He has held Medical Director roles at Recordati Rare Diseases and Alexion Pharmaceuticals. He has also held leadership positions at Abbvie and Novo Nordisk Pharmaceuticals. Dr. Yigit has served as an internal medicine physician at Manisa State Hospital. He has contributed to research as an assistant at ADU.